{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30813162", "DateCompleted": {"Year": "2019", "Month": "03", "Day": "11"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "08"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["e14543", "10.1097/MD.0000000000014543"], "Journal": {"ISSN": "1536-5964", "JournalIssue": {"Volume": "98", "Issue": "8", "PubDate": {"Year": "2019", "Month": "Feb"}}, "Title": "Medicine", "ISOAbbreviation": "Medicine (Baltimore)"}, "ArticleTitle": "Herbal medicines for metabolic diseases with blood stasis: A protocol for a systematic review and meta-analysis.", "Pagination": {"StartPage": "e14543", "MedlinePgn": "e14543"}, "Abstract": {"AbstractText": ["Herbal medicines have the potential to be alternative treatments for metabolic diseases. This systematic review will assess the efficacy of herbal medicines in treating metabolic diseases with blood stasis.", "We will search MEDLINE, the Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science, 2 Korean medical databases (OASIS, NDSL), a Chinese database (China National Knowledge Infrastructure, CNKI), and a Japanese database (J-STAGE) for relevant literature. We will include all randomized controlled trials (RCTs) or quasi-RCTs evaluating the effectiveness of herbal medicine. Participants of both sexes and of any age with clinically diagnosed metabolic disease with blood stasis will be included. Primary outcomes will include Blood-stasis syndrome score, TC, TG, HDL-C and LDL-C. Secondary outcomes will Blood pressure, FBS. ECG, prevalence rate of heart disease, and response rate. The risk of bias will be assessed using the Cochrane tool for assessing risk of bias.", "The findings of this study will provide a summary of the current state of evidence regarding the effectiveness of types of herbal medicine in managing metabolic disease with blood stasis. In addition, this review will be expected to provide a base for clinical trials to confirm the efficacy of herbal medicine for treatments of metabolic disease with blood stasis.", "PROSPERO 2018 CRD42018090179."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Medicine Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea."}], "LastName": "Ko", "ForeName": "Mi Mi", "Initials": "MM"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Jang", "ForeName": "Soobin", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Jung", "ForeName": "Jeeyoun", "Initials": "J"}], "PublicationTypeList": ["Journal Article", "Meta-Analysis", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Medicine (Baltimore)", "NlmUniqueID": "2985248R", "ISSNLinking": "0025-7974"}, "MeshHeadingList": [{"QualifierName": ["complications", "therapy"], "DescriptorName": "Blood Coagulation Disorders"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["methods"], "DescriptorName": "Herbal Medicine"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["complications", "therapy"], "DescriptorName": "Metabolic Diseases"}, {"QualifierName": ["methods"], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["drug effects"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Research Design"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}], "CoiStatement": "The authors declare that there are no competing interests regarding the publication of this paper."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "S&T Market Report, Market trend of treatment of metabolic disease, Commercialization Promotion Agency for R&D Outcome, 2015;27:2\u201329, Korea."}, {"Citation": "Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005;112:2735\u201352.", "ArticleIdList": ["16157765"]}, {"Citation": "Carr DB, Utzschneider KM, Hull RL, et al. Intra-abdominal fat is a major determinant of the National cholesterol education program adult treatment Panel III criteria for themetabolic syndrome. Diabetes 2004;53:2087\u201394.", "ArticleIdList": ["15277390"]}, {"Citation": "Ferrannini E, Haffner SM, Mitchell BD, et al. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991;34:416\u201322.", "ArticleIdList": ["1884900"]}, {"Citation": "Jang S, Jang BH, Ko Y, et al. Herbal medicines for treating metabolic syndrome: a systematic review of randomized controlled trials. Evid Based Complement Alternative Med 2016;2016:5936402doi:10.1155/2016/5936402.", "ArticleIdList": ["PMC4930818", "27413388"]}, {"Citation": "Cornier MA, Dabelea D, Hernandez TL, et al. The metabolic syndrome. Endocr Rev 2008;29:777\u2013822.", "ArticleIdList": ["PMC5393149", "18971485"]}, {"Citation": "International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. 2006; Available from: https://www.idf.org/e-library/consensus-statements/60-idfconsensus-worldwide-definitionof-the-metabolic-syndrome.html\nAccessed January 18, 2019."}, {"Citation": "Korean National Health and Nutrition Examination Survey. Korea Centers for Disease Control & Prevention. 2017; Available from: http://knhanes.cdc.go.kr, http://yhs.cdc.go.kr\nAccessed January 18, 2019."}, {"Citation": "Martin KA, Mani MV, Mani A. New targets to treat obesity and the metabolic syndrome. Eur J Pharmacol 2015;763:64\u201374.", "ArticleIdList": ["PMC4573317", "26001373"]}, {"Citation": "Nobili A, Garattini S, Mannucci PM. Multiple diseases and polypharmacy in the elderly: challenges for the internist of the third millennium. J Comorb 2011;1:28\u201344.", "ArticleIdList": ["PMC5556419", "29090134"]}, {"Citation": "Davies JT, Delfino SF, Feinberg CE, et al. Current and emerging uses of statins in clinical therapeutics: a review. Lipid Insights 2016;9:13\u201329.", "ArticleIdList": ["PMC5110224", "27867302"]}, {"Citation": "Cham S, Koslik HJ, Golomb BA. Mood, personality, and behavior changes during treatment with statins: a case series. Drug Saf Case Rep 2016;3:1doi: 10.1007/s40800-015-0024-2.", "ArticleIdList": ["PMC5005588", "27747681"]}, {"Citation": "Yuan H, Ma Q, Ye L, et al. The traditional medicine and modern medicine from natural products. Molecules 2016;21:E559doi: 10.3390/molecules21050559.", "ArticleIdList": ["PMC6273146", "27136524"]}, {"Citation": "Tabatabaei-Malazy O, Larijani B, Abdollahi M. Targeting metabolic disorders by natural products. J Diabetes Metab Disord 2015;14:57doi: 10.1186/s40200-015-0184-8. PMCID: PMC4495701.", "ArticleIdList": ["PMC4495701", "26157708"]}, {"Citation": "Pan SY, Zhou SF, Gao SH, et al. New perspectives on how to discover drugs from herbal medicines: CAM's outstanding contribution to modern therapeutics. Evid Based Complement Alternative Med 2013;2013:627375doi:10.1155/2013/627375.", "ArticleIdList": ["PMC3619623", "23634172"]}, {"Citation": "Chen KJ. Blood stasis syndrome and its treatment with activating blood circulation to remove blood stasis therapy. Chin J Integr Med 2012;18:891\u20136.", "ArticleIdList": ["23238996"]}, {"Citation": "Terasawa K. The presentation of diagnostic criteria for \u201cYu-xie\u201d (stagnated blood) conformation. Int J Oriental Med 1989;14:194\u2013213."}, {"Citation": "Park B, Yun KJ, Jung J, et al. Conceptualization and utilization of blood stasis syndrome among doctors of Korean medicine: results of a web-based survey. Am J Transl Res 2014;6:857\u201368.", "ArticleIdList": ["PMC4297353", "25628796"]}, {"Citation": "Liao J, Wang J, Liu Y, et al. Modern researches on Blood Stasis syndrome 1989-2015: a bibliometric analysis. Medicine (Baltimore) 2016;95:e5533doi: 10.1097/MD.0000000000005533.", "ArticleIdList": ["PMC5266019", "27930547"]}, {"Citation": "Go H, Ryuk JA, Hwang JT, et al. Effects of three different formulae of Gamisoyosan on lipid accumulation induced by oleic acid in HepG2 cells. Integr Med Res 2017;6:395\u2013403.", "ArticleIdList": ["PMC5741383", "29296566"]}, {"Citation": "Park SH, Sung YY, Jang S, et al. The Korean herbal medicine, Do In Seung Gi-Tang, attenuates atherosclerosis via AMPK in high-fat diet-induced ApoE(\u2212/\u2212) mice. BMC Complement Altern Med 2016;16:352doi: 10.1186/s12906-016-1309-4.", "ArticleIdList": ["PMC5016892", "27608856"]}]}], "History": [{"Year": "2019", "Month": "3", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "3", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "3", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "2", "Day": "22"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30813162", "PMC6408104", "10.1097/MD.0000000000014543", "00005792-201902220-00042"]}}]}